Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 7.15
+0.20 (2.88%)
At close: Jun 30, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 107.47 million as of July 3, 2025. Its market cap has increased by 58.43% in one year.
Market Cap
107.47M
Enterprise Value
101.97M
Revenue
15.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.15
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 115.59M to 107.47M, a decrease of -7.02%. That is a compound annual growth rate of -1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 107.47M | 55.21% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 857.89B |
| Atlas Copco AB | 715.74B |
| AB Volvo | 540.90B |
| EQT AB | 367.51B |
| Skandinaviska Enskilda Banken AB | 338.09B |
| ASSA ABLOY AB | 328.57B |
| Swedbank AB | 280.34B |
| Sandvik AB | 272.08B |